GRIN2B and early-onset autosomal dominant Alzheimer disease: Conceivably, our demonstration of genetic enhancement in both mice and rats via NR2B overexpression greatly strengthens the notion that the NR2B gene is a valid drug target for improving memory function in both normal brains and patients with Alzheimer' disease or mild cognitive impairment [21], [29].